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Introduction 
Malaria in pregnancy (MiP) is a significant contributor to maternal and newborn morbidity and 
mortality. In malaria-endemic countries, especially those in tropical areas of Africa where there is 
intense transmission of Plasmodium falciparum (P. falciparum), malaria infection directly contributes to 
adverse outcomes in maternal and newborn health. An estimated 11% of neonatal deaths in malaria-
endemic African countries are due to low birth weight resulting from P. falciparum infections in 
pregnancy. 1 According to the Roll Back Malaria (RBM) Initiative, malaria accounts for over 10,000 
maternal and between 75,000 and 200,000 infant deaths per year in Africa. 2 Prevention of MiP is thus a 
key public health intervention. 
The World Health Organization (WHO) recommends a multi-pronged approach to MiP. Intermittent 
preventive treatment for malaria in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) with at least 
three dosages, in addition to ensuring that pregnant women sleep under insecticide-treated nets (ITN) is 
critical to successfully preventing MiP. 1 The government of Kenya’s current policy on IPTp-SP supports a 
minimum of two doses of SP before birth. Recent data from Kenya demonstrates that 25 percent of 
Kenyan women are receiving the mandated two doses. 
The most recent DHS survey demonstrates that 60 percent of infants’ deaths occur during the first 
month of life. 2, 4 Given the high neonatal mortality rate and that many of these deaths could be 
attributed to MiP, it is imperative to improve adherence to the WHO MiP recommendation. 5 
Furthermore, the WHO most recent recommendation requires greater dosage than previous 
recommendations; therefore, it is critical that new and innovative approaches be implemented to 
improve IPTp-SP adherence. 3  
The WHO recommends also the use of community health workers (CHWs) to deliver IPTp-SP for 
pregnant women living in endemic areas, with targeted monitoring and evaluation. 5 The effects of using 
CHWs to distribute IPTp-SP to pregnant women may be mixed, as there is currently only low to 
moderate evidence for this approach. However, the WHO concluded that this intervention is probably 
acceptable and feasible, may have few undesirable effects, and may reduce inequalities by extending 
care to underserved populations. 5  
Activities  
PATH adopted a two-phased approach to: 
 increase coverage of MiP activities, with a special focus on increasing the uptake of IPTp-SP, and  
 strengthen antenatal care (ANC) in Kisumu, Kenya 
During the first phase PATH utilized a consultant to identify barriers and facilitators to ANC and the 
uptake of IPTp-SP.  The consultant held focus group discussions with CHWs, pregnant women, and ANC 
nurses to identify specific enablers and limitations to women attending ANC clinics and receiving their 
IPTp-SP dosage. Additionally, the consultant held key informant interviews with district officials, health 
workers, and community health extension workers (CHEWs) to gain specific perspectives on community 
approaches to IPTp-SP distribution. The consultant compiled the results of this qualitative review into a 
final report. 
During the second phase, PATH collaborated with health clinic staff and district officials to design and 
pilot a community-based approach to strengthening ANC and uptake of IPTp-SP in the East Kisumu 
district:  
 CHWs received a refresher training on malaria and the current Kenyan policy relevant to malaria 
control with an emphasis on current policies and the most recent WHO recommendations for 
MiP.  
 After the training, the CHWs returned to their communities to identify pregnant women. 
  During the CHWs’ routine home visits, they encourage pregnant women to attend the ANC 
clinic, review the maternal health booklets with the pregnant women and provide the missing 
dosage of IPTp-SP if it was not given during the ANC appointment or if an appointment was 
missed. 
 The CHWs note in the maternal health booklet the dosage provided to the pregnant women and 
included the uptake on their reporting sheet to the health clinic.  
Focus group discussions and key informant interviews. 
Between October and November 2013, the PATH consultant conducted a series of focus group 
discussions with pregnant women, CHWs, and community leaders. Additionally, he conducted 
interviews with key informants including representatives from the District Health Management Team, 
maternal and child health nurses, health facility leadership, and CHEWs.   
From the formative inquiry, we learned that a major reason why pregnant women don’t attend the ANC 
clinics is the negative attitude of some health workers. Staff attitudes and unfair treatment by the 
service providers were reported by most pregnant women as the reason why they fail to go to the ANC 
clinic. Women inform each other about their negative experiences, hence diminishing attendance and 
compliance further. Other reasons cited for not attending the ANC clinics included: lack of information, 
trust in traditional birth attendants (TBAs), stigma on HIV testing, long queues especially due to staff 
shortage, distance to health facilities, and shortage of essential drugs, including IPTp-SP tablets.  
There was consensus between the groups that CHW engagement in the distribution of IPTp-SP would be 
instrumental in both increasing ANC clinic attendance and the uptake of IPTp-SP. It was, however, noted 
that there would be a need for some adjustments in the current reporting and supervision systems to 
encourage CHW and to accurately account for drugs distributed, but that with proper implementation 
this could lead to a feasible and effective model for improving ANC and IPTp-SP uptake. 
There was little receptivity for a non-directly observed treatment (DOT) approach from health staff or 
community leaders. Some, however, suggested that men (husbands) could be targeted to be the ones to 
administer the IPTp-SP to their spouses.  
Overall, the consensus is that CHW engagement in the distribution of IPTp-SP would be instrumental in 
both increasing ANC clinic attendance and uptake of IPTp-SP. This would, however, require support by 
the community and from the health care system to ensure reliable reporting, appropriate drug supplies, 
and overall education on MiP prevention. 
Pilot community-based approach to strengthening ANC and uptake of IPTp-SP 
PATH initiated field activities in West Kisumu in October 2013. CHWs received a refresher training on 
malaria, including MiP, and were familiarized with the new reporting tools. The focus was first on raising 
awareness about the need for women to attend ANC clinics and prevent malaria during pregnancy by 
taking multiple monthly doses of IPTp-SP and sleeping under an ITN. During the month of November 
2013, CHW registered ANC-defaulters in their communities and prepared for community-/home-based 
IPTp-SP distribution to these defaulters, while the community health extension workers (CHEWS) and 
facility workers supported the community-based activities through supervision and by increasing the SP 
supply. Community-based distribution was established in community health units covering three health 
facilities in December 2013. 
As there was a concern that community based distribution of IPTp-SP would decrease ANC attendance 
and facility based uptake of IPTp-SP, PATH assessed the effect of these community activities on ANC 
attendance and IPTp-SP uptake in the three health facilities frequented by pregnant women in the 
communities covered by the CHWs trained in community-based distribution of IPTp-SP up to May 2014. 
We accessed data available through the national health information system in Kenya (dhis2) to monitor 
IPTp1, IPTp2, ANC1, and ANC4. A review of the ANC clinic attendance and IPTp uptake data covering the 
intervention area shows a moderate increase in ANC4 uptake as compared to the same period the 
previous year (figure1). 
 
We also compared ANC clinic attendance in the facilities covering the areas (intervention facilities) in 
which CHWs were trained in MiP with the ANC clinic attendance in similar facilities in Kisumu without 
the pilot (control facilities) and found that ANC4 clinic attendance was far better in the area covered by 
trained CHWs (figure 2).   
 We did not see a drop in ANC clinic attendance and IPTp uptake in the clinics serving the areas where 
CHWs distributed IPTp-SP. Whereas we had noted a drop-off in ANC clinic attendance (and IPTp uptake) 
in the months of November and December in 2012 and expected a bigger decrease in ANC clinic 
attendance in December 2013 due to a health worker strike on top of the end-of-the-year holidays. The 
start of the community-based activities, including IPTp-SP distribution, seemed to have had no negative 
impact on ANC clinic attendance and IPTp uptake in December 2013 and January 2014, as we saw an 
increase compared to the 2012/2013 baseline (figure 3). 
 The same increase in IPTp uptake was not seen in the control facilities (figure 4 and 5).   
 
 In addition to the IPTp-SP distribution during ANC at the facilities, CHW distributed IPTp-SP in their 
communities. During the first six months of community based IPTp-SP distribution, over 50 additional 
IPTp-SP treatments were distributed monthly by CHWs. CHWs provided an additional 50 percent doses 
of IPTp2 to pregnant women and increased the uptake of IPTp3 and IPTp4 (figure 6). 
In addition to IPTp, an additional 300 monthly doses of iron/folic acid were distributed by the CHWs in 
these first six months of the pilot.  
Community-based administration of IPTp-SP was thus well accepted by CHWs and pregnant women. 
CHWs showed enthusiasm for the additional tasks of identifying pregnant women, encouraging them to 
attend ANC clinics, and providing IPTp-SP to defaulters. They did this out of a sense of duty to serve their 
communities and because this activity added a sense of importance to their role in society. 
Conclusion 
Community-based approach  
Overall, a community-based approach through CHWs’ support showed promising results. CHWs 
expressed ongoing willingness to continue these activities, as they recognized the trust that pregnant 
women have in their advice and expertise. Furthermore, results indicate that ANC clinic attendance did 
not decrease (and might have increased) while SP uptake greatly improved.  
Additionally, this methodology is very feasible, requiring a small investment in conducting a one- or two-
day training for CHWs and health clinic practitioners. Furthermore, the CHWs will need to be equipped 
with a small supply of SP to distribute when necessary and additional support in reporting and 
supervision. 
Health facility interventions 
Given that many women reported that they are reluctant to attend ANC clinics because of the poor 
attitude of some health workers, there is the need for health managers to identify issues surrounding 
this attitude and develop strategies and design interventions as appropriate. Other facility interventions 
could include but should not be limited to: training and technical updates, supportive supervision, and 
provision of necessary materials and supplies at these health facilities. Other measures to address 
barriers to attending ANC clinics include continuous community sensitization on the many benefits of 
ANC clinic attendance. 
Overall 
Community-based approaches are a proven effective implementation strategy to improve drug 
adherence. CHWs are trusted members of the community who can appropriately advise pregnant 
women on best practices for a healthy pregnancy. The community-based approach still requires supply-
chain management through the health clinics to assure a reliable supply of SP. In addition to consistent 
training, support and supervision of CHWs are necessary to assure accurate information/reporting on 
implementation activities and drug distribution. 
Community-based approaches to improving MiP coverage, including IPTp-SP uptake and adherence, 
have demonstrated positive results in studies in Kenya, Uganda, Nigeria, and Malawi. Improved MiP 
adherence can result in a decrease in low birth weight and thus neonatal mortality.  
Challenges 
There were a number of manageable challenges in implementing this approach. Data collection 
presented the greatest concern as the process required additional data collection and reporting by the 
CHWs. This required designing monthly reporting sheets. Eventually, this data needs to be incorporated 
into the national data-collection process. Both the CHWs and the data processers will need to receive 
training on collecting and processing the additional data. Within the current data collection and 
reporting practices, it is not possible to add information to the national data-collection tool (e.g., to 
report on SP doses three, four, and beyond). 
Other challenges arose during the implementation of the pilot, including personnel changes at both the 
district and national levels. All new staff, however, continued to support the work. Additionally, during 
the pilot there were immunization campaigns which diverted many officials’, including health workers’, 
attention away from the MiP activities.   
Next Steps 
There have been a limited number of community-based studies conducted in Africa demonstrating the 
success of community-based MiP interventions. Like this pilot, many were small, and the results cannot 
be generalized to larger populations. The results, however, demonstrate the need for a scale-up in 
Kenya and other countries to fully demonstrate the impact community-based approaches can have on 
MiP outcomes.  
Through both the quantitative and qualitative approaches, it is clear that CHWs and health care 
providers need to receive ongoing training and supervision to assure high-quality and consistent 
implementation of ANC, including MiP, guidelines, and policies.  
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